1-2 of 2
Bertrand Coiffier, MD PhD Prof
Close
Save search
Sort by
Journal Articles

Romidepsin Induces Durable Responses in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)

Free
Barbara Pro, MD, Steven M. Horwitz, MD, H. Miles Prince, MB BS (Hons) MDFRACP FRCPA AFRACMA MACD, Francine M. Foss, MD, Lubomir Sokol, MD PhD, Matthew Greenwood, MD FRACP, FRCPA, Dolores Caballero, Franck Morschhauser, MD PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, Prof, MD FACP, Swaminathan Padmanabhan Iyer, MD Dir, Hematological Malignancies, Andrei R. Shustov, MD, Julie Wolfson, MPH, Barbara E Balser, VMD, Bertrand Coiffier, MD PhD Prof
Journal: Blood
Blood (2014) 124 (21): 1742.
https://doi.org/10.1182/blood.V124.21.1742.1742
Published: 2014
Journal Articles

Second Interim Analysis of a Phase 3 Study of Idelalisib (ZYDELIG ® ) Plus Rituximab (R) for Relapsed Chronic Lymphocytic Leukemia (CLL): Efficacy Analysis in Patient Subpopulations with Del(17p) and Other Adverse Prognostic Factors

Free
Jeff P. Sharman, MD, Steven E. Coutre, MD, Richard R. Furman, MD, Bruce D. Cheson, John M. Pagel, MD PhD, Peter Hillmen, MBChB, PhD, Jacqueline C. Barrientos, MD, Andrew D. Zelenetz, MD PhD, Thomas J. Kipps, MD PhD, Ian W. Flinn, MD PhD, Paolo Ghia, MD, Michael Hallek, MD, Bertrand Coiffier, MD PhD Prof, Susan O'Brien, Eugen Tausch, MD, Karl-Anton Kreuzer, MD, Wendy Jiang, PhD, Mirella Lazarov, PhD, Daniel Li, PhD, Thomas M. Jahn, MD PhD, Stephan Stilgenbauer, MD
Journal: Blood
Blood (2014) 124 (21): 330.
https://doi.org/10.1182/blood.V124.21.330.330
Published: 2014